Literature DB >> 21928285

Expansion of a restricted residual host T reg-cell repertoire is dependent on IL-2 following experimental autologous hematopoietic stem transplantation.

Allison L Bayer1, Jackeline Chirinos, Cecilia Cabello, Jing Yang, Takaji Matsutani, Thomas R Malek, Robert B Levy.   

Abstract

We previously identified a population of residual T(reg) cells following autologous hematopoietic stem transplantation (HSCT), that rapidly undergoes significant expansion in lymphopenic transplant recipients prior to repopulation by donor de novo derived T(reg) cells. These CD4(+) Foxp3(+) T cells provide protection from the development of autoimmune disease. Although ablative conditioning results in excess IL-7 and IL-15, IL-2 is typically not found at high levels following autologous HSCT. We therefore examined the role of these three STAT-5 signaling cytokines in the expansion of residual T(reg) cells after autologous HSCT. The present study found that the residual T(reg) cell population included surviving peripheral host Foxp3(+) CD4(+) T cells whose expansion was critically dependent on IL-2, which could be solely provided by surviving host cells. IL-7 was found to contribute to T(reg) cell homeostasis, however, not as a growth factor but rather for their persistence. In conjunction with this expansion, TCR spectratype analyses revealed that the residual host T(reg) -cell compartment differed from that present in non-conditioned healthy mice since the residual host Treg cells exhibit a limited TCR diversity. Collectively, these data indicate that the proliferation of T(reg) and T effector (T(eff) ) cells post-HSCT utilize separate pools of cytokines which has important implications regarding the development of clinical strategies to elicit the desired immune responses in patients post-transplant.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21928285      PMCID: PMC3516388          DOI: 10.1002/eji.201141611

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  51 in total

1.  IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation.

Authors:  Onder Alpdogan; Stephanie J Muriglan; Jeffrey M Eng; Lucy M Willis; Andrew S Greenberg; Barry J Kappel; Marcel R M van den Brink
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

2.  Early IL-2 production by mouse dendritic cells is the result of microbial-induced priming.

Authors:  Francesca Granucci; Sonia Feau; Véronique Angeli; François Trottein; Paola Ricciardi-Castagnoli
Journal:  J Immunol       Date:  2003-05-15       Impact factor: 5.422

3.  Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells.

Authors:  Qizhi Tang; Kammi J Henriksen; Elisa K Boden; Aaron J Tooley; Jianqin Ye; Sumit K Subudhi; Xin X Zheng; Terry B Strom; Jeffrey A Bluestone
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

4.  2-Gy whole-body irradiation significantly alters the balance of CD4+ CD25- T effector cells and CD4+ CD25+ Foxp3+ T regulatory cells in mice.

Authors:  Yanyan Qu; Baojun Zhang; Shuchun Liu; Aijun Zhang; Tingting Wu; Yong Zhao
Journal:  Cell Mol Immunol       Date:  2010-09-27       Impact factor: 11.530

Review 5.  Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance.

Authors:  S Sakaguchi; N Sakaguchi; J Shimizu; S Yamazaki; T Sakihama; M Itoh; Y Kuniyasu; T Nomura; M Toda; T Takahashi
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

6.  IL-15 and cognate antigen successfully expand de novo-induced human antigen-specific regulatory CD4+ T cells that require antigen-specific activation for suppression.

Authors:  Hans J P M Koenen; Esther Fasse; Irma Joosten
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

7.  Elevated serum interleukin-15 level in acute graft-versus-host disease after hematopoietic cell transplantation.

Authors:  Ki-wai Chik; Karen Li; Henry Pong; Matthew Ming-kong Shing; Chi-Kong Li; Patrick Man-pan Yuen
Journal:  J Pediatr Hematol Oncol       Date:  2003-12       Impact factor: 1.289

8.  Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance.

Authors:  Andrey Antov; Lili Yang; Monika Vig; David Baltimore; Luk Van Parijs
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

9.  In situ activation and expansion of host tregs: a new approach to enhance donor chimerism and stable engraftment in major histocompatibility complex-matched allogeneic hematopoietic cell transplantation.

Authors:  Alwi Shatry; Robert B Levy
Journal:  Biol Blood Marrow Transplant       Date:  2009-05-07       Impact factor: 5.742

10.  CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2.

Authors:  Thomas R Malek; Aixin Yu; Vladimir Vincek; Paul Scibelli; Lin Kong
Journal:  Immunity       Date:  2002-08       Impact factor: 31.745

View more
  8 in total

1.  Adoptive T Regulatory Cell Therapy for Tolerance Induction.

Authors:  Cecilia Cabello-Kindelan; Shane Mackey; Allison L Bayer
Journal:  Curr Transplant Rep       Date:  2015-06-01

2.  Host-derived CD4+ T cells attenuate stem cell-mediated transfer of autoimmune arthritis in lethally irradiated C57BL/6.g7 mice.

Authors:  Narendiran Rajasekaran; Nan Wang; Phi Truong; Cornelia Rinderknecht; Claudia Macaubas; Georg F Beilhack; Judith A Shizuru; Elizabeth D Mellins
Journal:  Arthritis Rheum       Date:  2013-03

3.  Use of Post-transplant Cyclophosphamide Treatment to Build a Tolerance Platform to Prevent Liquid and Solid Organ Allograft Rejection.

Authors:  Casey O Lightbourn; Dietlinde Wolf; Sabrina N Copsel; Ying Wang; Brent J Pfeiffer; Henry Barreras; Cameron S Bader; Krishna V Komanduri; Victor L Perez; Robert B Levy
Journal:  Front Immunol       Date:  2021-03-02       Impact factor: 7.561

Review 4.  Recipient Tregs: Can They Be Exploited for Successful Hematopoietic Stem Cell Transplant Outcomes?

Authors:  Sabrina N Copsel; Dietlinde Wolf; Brent Pfeiffer; Henry Barreras; Victor L Perez; Robert B Levy
Journal:  Front Immunol       Date:  2022-06-21       Impact factor: 8.786

Review 5.  The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy.

Authors:  Chris Fraker; Allison L Bayer
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

6.  Immunomodulation Followed by Antigen-Specific Treg Infusion Controls Islet Autoimmunity.

Authors:  Cecilia Cabello-Kindelan; Shane Mackey; Alexander Sands; Jennifer Rodriguez; Claudia Vazquez; Alberto Pugliese; Allison L Bayer
Journal:  Diabetes       Date:  2019-11-11       Impact factor: 9.461

Review 7.  Lymphopenia is detrimental to therapeutic approaches to type 1 diabetes using regulatory T cells.

Authors:  Shifra Ash; Shai Yarkoni; Nadir Askenasy
Journal:  Immunol Res       Date:  2014-01       Impact factor: 2.829

8.  Efficient Killing of High Risk Neuroblastoma Using Natural Killer Cells Activated by Plasmacytoid Dendritic Cells.

Authors:  Martine Cordeau; Assila Belounis; Martin Lelaidier; Paulo Cordeiro; Hervé Sartelet; Sabine Herblot; Michel Duval
Journal:  PLoS One       Date:  2016-10-07       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.